-
Dec 2008
Retrovirally mediated overexpression of glycosaminoglycan-deficient biglycan in arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointimae after vascular injury.
Am J PatholHwang JY, Johnson PY, Braun KR, Hinek A, Fischer JW, O'Brien KD, Starcher B, Clowes AW, Merrilees MJ, Wight TN -
Dec 2008
Type 1 Diabetes TrialNet--an international collaborative clinical trials network.
Ann N Y Acad SciSkyler JS, Greenbaum CJ, Lachin JM, Leschek E, Rafkin-Mervis L, Savage P, Spain L, Type 1 Diabetes TrialNet Study Group. -
Dec 2008
Athsq1 is an atherosclerosis modifier locus with dramatic effects on lesion area and prominent accumulation of versican.
Arterioscler Thromb Vasc BiolSeidelmann SB, Kuo C, Pleskac N, Molina J, Sayers S, Li R, Zhou J, Johnson P, Braun K, Chan C, Teupser D, Breslow JL, Wight TN, Tall AR, Welch CL -
Nov 2008
The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells.
J ImmunolSchneider A, Rieck M, Sanda S, Pihoker C, Greenbaum CJ, Buckner JH -
Nov 2008
Reversal of thymic stromal lymphopoietin-induced airway inflammation through inhibition of Th2 responses.
J ImmunolZhou B, Headley MB, Aye T, Tocker J, Comeau MR, Ziegler SF -
Nov 2008
Functional analysis of FOXP3.
Ann N Y Acad SciBuckner JH, Ziegler SF -
Oct 2008
Cutting edge: Inhibition of NF-kappaB-mediated TSLP expression by retinoid X receptor.
J ImmunolLee HC, Headley MB, Iseki M, Ikuta K, Ziegler SF -
Oct 2008
Insulin protein and proliferation in ductal cells in the transplanted pancreas of patients with type 1 diabetes and recurrence of autoimmunity.
DiabetologiaMartin-Pagola A, Sisino G, Allende G, Dominguez-Bendala J, Gianani R, Reijonen H, Nepom GT, Ricordi C, Ruiz P, Sageshima J, Ciancio G, Burke GW, Pugliese A -
Oct 2008
Approaching the Heisenberg principle of immunology.
Clin ImmunolNepom GT -
Oct 2008
Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes.
Diabetes CareGreenbaum CJ, Mandrup-Poulsen T, McGee PF, Battelino T, Haastert B, Ludvigsson J, Pozzilli P, Lachin JM, Kolb H, Type 1 Diabetes Trial Net Research Group., European C-Peptide Trial Study Group. -
Oct 2008
The anthrax vaccine adsorbed vaccine generates protective antigen (PA)-Specific CD4+ T cells with a phenotype distinct from that of naive PA T cells.
Infect ImmunKwok WW, Yang J, James EA, Bui J, Huston L, Wiesen AR, Roti M -
Sep 2008
Intradermal administration of thymic stromal lymphopoietin induces a T cell- and eosinophil-dependent systemic Th2 inflammatory response.
J ImmunolJessup HK, Brewer AW, Omori M, Rickel EA, Budelsky AL, Yoon BR, Ziegler SF, Comeau MR -
Aug 2008
TSLP acts on infiltrating effector T cells to drive allergic skin inflammation.
Proc Natl Acad Sci U S AHe R, Oyoshi MK, Garibyan L, Kumar L, Ziegler SF, Geha RS -
Aug 2008
Characterization of effector functions of human peptide-specific CD4+ T-cell clones for an intracellular pathogen.
Hum ImmunolKlucar P, Barnes PF, Kong Y, Samten B, Tvinnereim A, Spallek R, Nepom GT, Singh M, Shams H -
Aug 2008
CD4+ T cells from type 1 diabetic and healthy subjects exhibit different thresholds of activation to a naturally processed proinsulin epitope.
J AutoimmunYang J, Danke N, Roti M, Huston L, Greenbaum CJ, Pihoker C , James EA, Kwok WW
